|NIR will also be introduced as one of FDA's PAT-Initiative key technologies - at the
University of Heidelberg PAT Conference
with FDA and EU Authority Speakers
– co-sponsored by ECA. Get the latest update in Heidelberg from 27-29 September.
Among the Speakers are
- Dr Chris Watts, FDA, Member of the PAT Policy Team,
- Prof Christina Graffner, MPA, Expert of the ad hoc EU-PAT group of
EMEA's scientific committees,
- Dr Ajaz Hussain, Sandoz Inc., USA, formerly FDA's PAT Expert Group
as well as Speakers from SanofiAventis, Astra Zeneca, Roche,
GlaxoSmithKline, Schering and many more.
Please visit: www.pat-conference.org